| A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT … I Tachibana, Y Nishimura, T Shibata, S Kanamori, K Nakamatsu, R Koike, ... Journal of Radiation Research 54 (6), 1078-1084, 2013 | 66 | 2013 |
| Multi-institutional evaluation of knowledge-based planning performance of volumetric modulated arc therapy (VMAT) for head and neck cancer T Kamima, Y Ueda, J Fukunaga, Y Shimizu, M Tamura, K Ishikawa, ... Physica Medica 64, 174-181, 2019 | 38 | 2019 |
| Mechanical performance of a commercial knowledge-based VMAT planning for prostate cancer M Tamura, H Monzen, K Matsumoto, K Kubo, M Otsuka, M Inada, H Doi, ... Radiation Oncology 13, 1-7, 2018 | 30 | 2018 |
| Neutrophil–to–lymphocyte ratio predicts survival after whole-brain radiotherapy in non-small cell lung cancer H Doi, K Nakamatsu, S Anami, K Fukuda, M Inada, H Tatebe, K Ishikawa, ... in vivo 33 (1), 195-201, 2019 | 27 | 2019 |
| Is concurrent chemotherapy with radiotherapy for esophageal cancer beneficial in patients aged 80 years or older? K Jingu, N Takahashi, Y Murakami, K Ishikawa, S Itasaka, T Takahashi, ... Anticancer Research 39 (8), 4279-4283, 2019 | 25 | 2019 |
| Comparing the 7th and 8th editions of the American Joint Committee on Cancer/Union for International Cancer Control TNM staging system for esophageal squamous cell carcinoma … M Inada, Y Nishimura, K Ishikawa, K Nakamatsu, Y Wada, T Uehara, ... Esophagus 16, 371-376, 2019 | 24 | 2019 |
| A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015) Y Nishimura, S Ishikura, T Shibata, T Kodaira, Y Ito, K Tsuchiya, ... International journal of clinical oncology 25, 1250-1259, 2020 | 23 | 2020 |
| Serum lactate dehydrogenase predicts survival in small-cell lung cancer patients with brain metastases that were treated with whole-brain radiotherapy S Anami, H Doi, K Nakamatsu, T Uehara, Y Wada, K Fukuda, M Inada, ... Journal of Radiation Research 60 (2), 257-263, 2019 | 22 | 2019 |
| Multiple primary malignancies in patients with prostate cancer: increased risk of secondary malignancies after radiotherapy K Okajima, K Ishikawa, T Matsuura, H Tatebe, K Fujiwara, K Hiroi, ... International journal of clinical oncology 18, 1078-1084, 2013 | 22 | 2013 |
| Safety and efficacy of cetuximab-containing chemotherapy after immune checkpoint inhibitors for patients with squamous cell carcinoma of the head and neck: a single-center … T Kurosaki, S Mitani, K Tanaka, S Suzuki, H Kanemura, K Haratani, ... Anti-Cancer Drugs 32 (1), 95-101, 2021 | 19 | 2021 |
| Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1) M Inada, Y Nishimura, S Ishikura, K Ishikawa, N Murakami, T Kodaira, ... Radiation Oncology 17 (1), 133, 2022 | 15 | 2022 |
| Dose–volume histogram analysis and clinical evaluation of knowledge-based plans with manual objective constraints for pharyngeal cancer T Uehara, H Monzen, M Tamura, K Ishikawa, H Doi, Y Nishimura Journal of Radiation Research 61 (3), 499-505, 2020 | 15 | 2020 |
| Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity … T Kusada, T Toita, T Ariga, W Kudaka, H Maemoto, W Makino, K Ishikawa, ... International journal of clinical oncology 25, 1977-1984, 2020 | 14 | 2020 |
| Tumor hypoxia detected by 18F-fluoromisonidazole positron emission tomography (FMISO PET) as a prognostic indicator of radiotherapy (RT) I Tachibana, Y Nishimura, K Hanaoka, M Inada, K Fukuda, H Tatebe, ... Anticancer Research 38 (3), 1775-1781, 2018 | 14 | 2018 |
| Clinical outcomes of IMRT planned with or without PET/CT simulation for patients with pharyngeal cancers T Matsuura, Y Nishimura, K Nakamatsu, S Kanamori, K Ishikawa, ... International journal of clinical oncology 22, 52-58, 2017 | 14 | 2017 |
| Clinical results of definitive-dose (50 Gy/25 fractions) preoperative chemoradiotherapy for unresectable esophageal cancer K Ishikawa, K Nakamatsu, O Shiraishi, T Yasuda, Y Nishimura International Journal of Clinical Oncology 20, 531-537, 2015 | 14 | 2015 |
| Dose-volume histogram analysis of knowledge-based volumetric-modulated arc therapy planning in postoperative breast cancer irradiation E Inoue, H Doi, H Monzen, M Tamura, M Inada, K Ishikawa, K Nakamatsu, ... in vivo 34 (3), 1095-1101, 2020 | 13 | 2020 |
| Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer H Ueda, M Takeda, S Ueda, H Kawakami, T Okuno, N Takegawa, ... Oncotarget 8 (46), 80286, 2017 | 10 | 2017 |
| Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: Retrospective study on predictive factors T Uehara, H Doi, K Ishikawa, M Inada, S Tatsuno, Y Wada, Y Oguma, ... Head & Neck 43 (10), 3132-3141, 2021 | 9 | 2021 |
| Transarterial chemoembolization for the palliation of painful bone metastases refractory to first-line radiotherapy J Heianna, W Makino, M Toguchi, T Iraha, K Ishikawa, T Kusada, ... Journal of Vascular and Interventional Radiology 32 (3), 384-392, 2021 | 9 | 2021 |
